News & AnalysisDeepcell nets $73m Series BDeepcell, a life science company, has raised $73 million in Series B financing.ByIris Dorbian18 March 2022•1 min readJavaScript is required to read this article. Please enable it in your browser and reload the page.DealsHealthcareBriefs